Aliqopa Copanlisib 60 mg

Strength Available :- 60 mg

Form :- Injection

Dosage :- Recommende dosage for (FL) is 60 mg via 1-hour IV infusion on Days 1, 8, and 15 of a 28-day treatment cycle on an intermittent schedule (3 weeks on and 1 week off).Duration of Therapy: Until disease progression or unacceptable toxicity.

Storage :- Store at 2ºC to 8ºC

Is The Medicine FDA Approved :- Yes

Date of Approval :- September 14, 2017

Common side effects are Black, tarry stools, bleeding gums, blood in the urine or tools, blurred vision, chest pain, chills, cough, cracks in the skin,  dizziness, dry mouth, fatigue, flushed, dry skin, fruit-like breath odor, headache,increased hunger, increased thirst, increased , urination, loss of heat from the body, lower back or side pain, nausea, nervousness, painful or difficult urination, pale skin, pinpoint red spots on the skin, pounding in the ears, red, swollen skin, scaly skin, slow or fast heartbeat, sneezing, sore throat, sores, ulcers, or white spots on the lips or in the mouth, stomach pain, sweating, swollen glands, tightness in the chest, troubled breathing, unexplained weight loss, unusual bleeding or bruising, unusual tiredness or weakness, vomiting.

Pack of 1 vial